Spectrum of Wegener granulomatosis in a Mexican population

Annals of the New York Academy of Sciences

Volumn 1107, Issue , 2007, Pages 400-409

  Flores Súarez, Luis Felipe ^a,b   Villa, Antonio R ^b  

^a Department of Immunology and Rheumatology ^*  (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

ANCA; Clinical characteristics; Wegener granulomatosis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGE DISTRIBUTION; COHORT ANALYSIS; CONFERENCE PAPER; DISEASE CLASSIFICATION; FEMALE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; RELAPSE; REMISSION; RISK FACTOR; SEX RATIO; WEGENER GRANULOMATOSIS; ARTICLE; FOLLOW UP; MEXICO; MIDDLE AGED; PATHOLOGY;

FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEXICO; MIDDLE AGED; WEGENER GRANULOMATOSIS;

EID: 34648817573     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1381.042     Document Type: Conference Paper

References (18)

1. KOLDINGSNES, W. & H. NOSSENT. 2000. Epidemiology of Wegener's granulomatosis in northern Norway. Arthritis Rheum. 43: 2481-2487.
2. GONZÁLEZ-GAY, M.A., C. GARCÍA- PORRÚA, J. GUERRERO, et al. 2003. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions. Arthritis Rheum. 49: 388-393.
3. GIBSON, A., L.K. STAMP, P.T. CHAPMAN, et al. 2006. The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a southern hemisphere region. Rheumatology (Oxford) 45: 624-628.
4. CISTERNAS, M., L. SOTO, S. JACOBELLI, et al. 2005. Características clínicas de granulomatosis de Wegener y poliangeítis microscópica en pacientes chilenos. Rev. Med. Chil. 133: 273-278.
5. FLORES-SUÁREZ, L.F. 2006. Remission of severe relapsing or persistent lupus nephritis using mycophenolate mofetil. Arch. Med. Res. 37: 68-73.
6. LEAVITT, R.Y., A.S. FAUCI, D.A. BLOCH, et al. 1990. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 33: 1101-1107.
7. JENNETTE, J.C., R.J. FALK, K. ANDRASSY, et al. 1994. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum. 37: 187-192.
8. EXLEY, A.R., P.A. BACON, R.A. LUQMANI, et al. 1998. Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI). Br. J. Rheumatol. 37: 57-63.
9. STOEN, J.H., G.S. HOFFMAN, P.A. MERKEL, et al. 2001. A disease specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum. 44: 912-920.
10. ROSETE, A., A. CABRAL, A. KRAUS, et al. 1991. Diabetes insipidus secondary to Wegener's granulomatosis: report and review of the literature. J. Rheumatol. 18: 761-765.
11. FLORES-SUÁREZ, L.F. 2006. Rituximab is useful in refractory Wegener granulomatosis with predominant granulomatous disease. [abstract.] Arthritis Rheum. 54: S493.
12. FLORES-SUÁREZ, L.F. 2004. De dificultades, retos y otras enfermedades. Revista Mexicana de Reumatologia 19: 189-190.
13. BLIGNY, D., A. MAHR, P.L. TOUMELIN, et al. 2004. Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based in 93 patients. Arthritis Rheum. 51: 83-91.
14. MATTESON, E.L., K.N. GOLD & D.A. BLOCH. 1996. Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's granulomatosis classification criteria cohort. Am. J. Med. 101: 129-134.
15. REINHOLD-KELLER, E., N. BEUGE, U. LATZA, et al. 2000. An interdisciplinary approach to the care of patients with Wegener's granulomatosis. Long-term outcome in 155 patients. Arthritis Rheum. 43: 1021-1032.
16. WESTMAN, K.W., P.G. BYGREN, H. OLSSON, et al. 1998. Relapse rate, renal survival and cancer morbidity on patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J. Am. Soc. Nephrol. 9: 842-852.
17. HARPER, L. & C.O. SAVAGE. 2005. ANCA associated renal vasculitis at the end of the twentieth century - a disease of older patients. Rheumatology (Oxford) 44: 495-501.
18. STONE, J.H., J.T. HOLBROOK, M.A. MARRIOTT, et al. 2006. Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial. Arthritis Rheum. 54: 1608-1618.